Aarti Pharmalabs Limited announces results of 7th AGM held on September 22, 2026
Aarti Pharmalabs · Pharmaceuticals & Biotechnology
Key highlights
- All resolutions proposed at the AGM were passed with requisite majority via e-voting and VC
- Key resolutions include appointment of Shri Rashesh C. Gogri as Managing Director from Oct 1, 2026
- Final dividend of ₹2 per equity share for FY ended March 31, 2026 was approved by shareholders
Why it's rated notable: All six resolutions were passed, but one director was not re-appointed and the two management designation resolutions drew 47.69524718% and 45.26333721% public-institution votes against, with no business or financial figures in the filing.
Original filing
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Aarti Pharmalabs
- Financial resultsMajor developmentAarti Pharmalabs approves Sept 2026 results; CFO Piyush Lakhani resigns
- Capex / expansionMajor developmentAarti Pharmalabs Limited reports Q1 FY 2026-27 results and approves director role changes
- Financial resultsMajor developmentAarti Pharmalabs Ltd announces Q1 FY 2026-27 results and role changes in management
- Capex / expansionMajor developmentAarti Pharmalabs reports quarter ended June 30, 2026 results; approves Rs.149 Crores capex
- Capex / expansionNotableAarti Pharmalabs inaugurates new manufacturing block at Tarapur to expand capacity
Other board / shareholder meeting outcome filings this fortnight
- Board / shareholder meeting outcomeUjjivan Small Finance BankUjjivan Small Finance Bank holds EGM approving preferential issuance of shares
- Board / shareholder meeting outcomeUsha Financial ServicesUsha Financial Services proposes EGM to approve bonus shares and capital increase
- Board / shareholder meeting outcomeOSEL DevicesOsel Devices Limited holds 01st EGM and approves issuance of convertible warrants
- IIFL Finance seeks EGM approval on 4 Dec 2026 for preferential issue of CCPS, warrants
- Regency Fincorp EGM approves capital hike, share and warrant preferential issues, ESOP
- Regency Fincorp Limited announces voting results of 2nd Extraordinary General Meeting 2026
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.